Barbara Oesch‐Bartlomowicz

Author

Johannes Gutenberg University Mainz ORCID

Also Known As

B Oesch-Bartlomowicz, B. Oesch-Bartlomowicz, B. Oesch-Bartlomowicz,, Barbara Oesch-Bartlomowicz, Barbara Oesch‐Bartlomowicz, Oesch-Bartlomowicz, Barbara

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz

About

Barbara Oesch‐Bartlomowicz is an author at Johannes Gutenberg University Mainz specializing in medicine, biochemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	263
2	Biochemistry	3	3	72
3	Natural Sciences	1	1	46
4	Public Health	1	1	94
5	Biomolecular Engineering	1	1	15

Barbara Oesch‐Bartlomowicz

Publications

564

Citations

H-Index

Page 1

	Year	Citations
Aryl hydrocarbon receptor activation by cAMP vs. dioxin: Divergent signaling pathways Barbara Oesch‐Bartlomowicz, Andrea Huelster, Oliver Wiss, Proceedings of the National Academy of Sciences	2005	178
Environmental exposure to dioxins and polychlorinated biphenyls reduce levels of gonadal hormones in newborns: Results from the Duisburg cohort study Yuguang Cao, Gerhard Winneke, Michael Wilhelm, International Journal of Hygiene and Environmental Health Endocrine DisruptorsEarly Life ExposureEnvironmental ExposureDevelopmental ToxicologyEnvironmental Health	2007	94
TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A Dagmar Faust, Ilona Schreck, Albert L. Ruff, Oncogene InflammationSignal TransductionSignaling PathwayMedicineLiver Physiology	2007	77
Differential p38-dependent signalling in response to cellular stress and mitogenic stimulation in fibroblasts Dagmar Faust, Christina Schmitt, Franz Oesch, Cell Communication and Signaling	2012	63
Differential Modulation of CYP2E1 Activity by cAMP-Dependent Protein Kinase upon Ser129Replacement Barbara Oesch‐Bartlomowicz, P. R. Padma, Roger L. Becker, Experimental Cell Research Molecular PharmacologyProtein FunctionSignal TransductionSignaling PathwayBiochemistry	1998	46
Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma Jan G. Hengstler, Alexandra Kett, Michael Arand, Cancer Letters Oncogenic AgentMedicineM1 Gene DefectsPathologyCancer Biology	1998	35
cAMP-dependent phosphorylation of CYP2B1 as a functional switch for cyclophosphamide activation and its hormonal controlin vitro andin vivo Barbara Oesch‐Bartlomowicz, Bernd Richter, Roger Becker, International Journal of Cancer	2001	34
Control of the mutagenicity of aromatic amines by protein kinases and phosphatases Barbara Oesch‐Bartlomowicz, H. J. Arens, Bernd Richter, Archives of Toxicology BiochemistryDrug DiscoveryProtein KinasesAromatic AminesProtein Phosphorylation	1997	15
Mechanism-based predictions of interactions. Franz Oesch, Barbara Oesch‐Bartlomowicz, J. F. Arens, Environmental Health Perspectives Toxic EffectsMetabolic ModelToxicological MechanismMechanism-based PredictionsMetabolic Pathway Analysis	1994	11
Generation and characterization of tTS‐H4: a novel transcriptional repressor that is compatible with the reverse tetracycline‐controlled TET‐ON system Ernesto Bockamp, C Christel, Dorothe Hameyer, The Journal of Gene Medicine	2007	11

Page 1